Correlation Between Fidelity Advisor and Extended Market

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fidelity Advisor and Extended Market at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity Advisor and Extended Market into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fidelity Advisor Biotechnology and Extended Market Index, you can compare the effects of market volatilities on Fidelity Advisor and Extended Market and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity Advisor with a short position of Extended Market. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity Advisor and Extended Market.

Diversification Opportunities for Fidelity Advisor and Extended Market

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Fidelity and Extended is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity Advisor Biotechnology and Extended Market Index in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Extended Market Index and Fidelity Advisor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity Advisor Biotechnology are associated (or correlated) with Extended Market. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Extended Market Index has no effect on the direction of Fidelity Advisor i.e., Fidelity Advisor and Extended Market go up and down completely randomly.

Pair Corralation between Fidelity Advisor and Extended Market

Assuming the 90 days horizon Fidelity Advisor Biotechnology is expected to under-perform the Extended Market. In addition to that, Fidelity Advisor is 1.31 times more volatile than Extended Market Index. It trades about -0.16 of its total potential returns per unit of risk. Extended Market Index is currently generating about 0.14 per unit of volatility. If you would invest  2,261  in Extended Market Index on September 15, 2024 and sell it today you would earn a total of  199.00  from holding Extended Market Index or generate 8.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Fidelity Advisor Biotechnology  vs.  Extended Market Index

 Performance 
       Timeline  
Fidelity Advisor Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fidelity Advisor Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.
Extended Market Index 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Extended Market Index are ranked lower than 10 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Extended Market may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Fidelity Advisor and Extended Market Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fidelity Advisor and Extended Market

The main advantage of trading using opposite Fidelity Advisor and Extended Market positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity Advisor position performs unexpectedly, Extended Market can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extended Market will offset losses from the drop in Extended Market's long position.
The idea behind Fidelity Advisor Biotechnology and Extended Market Index pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance